Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000561081 | SCV000674720 | likely benign | Hereditary cancer-predisposing syndrome | 2017-07-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001398744 | SCV001600519 | likely benign | Retinoblastoma | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000561081 | SCV002530791 | likely benign | Hereditary cancer-predisposing syndrome | 2020-10-19 | criteria provided, single submitter | curation | |
Prevention |
RCV003905494 | SCV004719281 | likely benign | RB1-related disorder | 2021-12-31 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV001398744 | SCV004844670 | benign | Retinoblastoma | 2023-11-02 | criteria provided, single submitter | clinical testing |